Optimal antiplatelet therapy in patients with acute coronary syndrome and chronic kidney disease: for the Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-11) study group

Optimal antiplatelet therapy in patients with acute coronary syndrome and chronic kidney disease: for the Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-11) study group

Abstract Introduction Chronic kidney disease (CKD) is a well-documented risk factor for major adverse cardiac events and bleeding events. The optimal antiplatelet strategy for patients with CKD remains unclear, especially patients with glomerular filtration rate (GFR) < 30 ml/min. We aim to compa...

Full description

Saved in:
Bibliographic Details
Main Authors: Perel Nimrod, Marmor David, Taha Louay, Tabi Meir, Itshak Amsalem, Rafi Hitter, Tomer Maller, Nir Levy, Lior Lupu, Hezzy Shmueli, Sharon Bruoha, Tal Ovdat, Michael Glikson, Elad Asher
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Nephrology
Subjects:
Antiplateletu therapy
Acute coronary syndrome
Chronic kidney disease
Online Access:https://doi.org/10.1186/s12882-025-04227-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12882-025-04227-8

Similar Items